Cargando…

Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group

In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups. The process of forming national children's cancer groups is fraught with many hurdles, which va...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chi-kong, Kurkure, Purna, Arora, Ramandeep Singh, Chen, Bow Wen, Kirgizov, Kirill, Okamoto, Yasuhiro, Seksarn, Panya, Tang, Yongmin, Yoo, Keon Hee, Agarwal, Bharat, Chan, Godfrey C.F., Dalvi, Rashmi, Hori, Hiroki, Khan, Muhammad Saghir, Yu, Alice, Nakagawara, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581612/
https://www.ncbi.nlm.nih.gov/pubmed/37656946
http://dx.doi.org/10.1200/GO.23.00153
_version_ 1785122174471766016
author Li, Chi-kong
Kurkure, Purna
Arora, Ramandeep Singh
Chen, Bow Wen
Kirgizov, Kirill
Okamoto, Yasuhiro
Seksarn, Panya
Tang, Yongmin
Yoo, Keon Hee
Agarwal, Bharat
Chan, Godfrey C.F.
Dalvi, Rashmi
Hori, Hiroki
Khan, Muhammad Saghir
Yu, Alice
Nakagawara, Akira
author_facet Li, Chi-kong
Kurkure, Purna
Arora, Ramandeep Singh
Chen, Bow Wen
Kirgizov, Kirill
Okamoto, Yasuhiro
Seksarn, Panya
Tang, Yongmin
Yoo, Keon Hee
Agarwal, Bharat
Chan, Godfrey C.F.
Dalvi, Rashmi
Hori, Hiroki
Khan, Muhammad Saghir
Yu, Alice
Nakagawara, Akira
author_sort Li, Chi-kong
collection PubMed
description In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups. The process of forming national children's cancer groups is fraught with many hurdles, which varies among the countries. One of the basic requirements for running clinical trials is an affordable health care system in which most of the children with cancer can receive the proposed treatment. The health insurance coverage for children with cancer varies from <20% to as high as 100% among Asian countries, and the operation of clinical trials must also be adjusted accordingly. Shortage of research personnel is common, including medical, nursing, research coordinators, and data managers. The establishment of the Asian Pediatric Hematology and Oncology Group aims to provide a good platform for promotion of international clinical trials in the Asian countries.
format Online
Article
Text
id pubmed-10581612
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-105816122023-10-18 Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group Li, Chi-kong Kurkure, Purna Arora, Ramandeep Singh Chen, Bow Wen Kirgizov, Kirill Okamoto, Yasuhiro Seksarn, Panya Tang, Yongmin Yoo, Keon Hee Agarwal, Bharat Chan, Godfrey C.F. Dalvi, Rashmi Hori, Hiroki Khan, Muhammad Saghir Yu, Alice Nakagawara, Akira JCO Glob Oncol SPECIAL ARTICLES In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups. The process of forming national children's cancer groups is fraught with many hurdles, which varies among the countries. One of the basic requirements for running clinical trials is an affordable health care system in which most of the children with cancer can receive the proposed treatment. The health insurance coverage for children with cancer varies from <20% to as high as 100% among Asian countries, and the operation of clinical trials must also be adjusted accordingly. Shortage of research personnel is common, including medical, nursing, research coordinators, and data managers. The establishment of the Asian Pediatric Hematology and Oncology Group aims to provide a good platform for promotion of international clinical trials in the Asian countries. Wolters Kluwer Health 2023-09-01 /pmc/articles/PMC10581612/ /pubmed/37656946 http://dx.doi.org/10.1200/GO.23.00153 Text en © 2023 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle SPECIAL ARTICLES
Li, Chi-kong
Kurkure, Purna
Arora, Ramandeep Singh
Chen, Bow Wen
Kirgizov, Kirill
Okamoto, Yasuhiro
Seksarn, Panya
Tang, Yongmin
Yoo, Keon Hee
Agarwal, Bharat
Chan, Godfrey C.F.
Dalvi, Rashmi
Hori, Hiroki
Khan, Muhammad Saghir
Yu, Alice
Nakagawara, Akira
Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
title Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
title_full Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
title_fullStr Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
title_full_unstemmed Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
title_short Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
title_sort current challenges of asian national children's cancer study groups on behalf of asian pediatric hematology and oncology group
topic SPECIAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581612/
https://www.ncbi.nlm.nih.gov/pubmed/37656946
http://dx.doi.org/10.1200/GO.23.00153
work_keys_str_mv AT lichikong currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT kurkurepurna currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT aroraramandeepsingh currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT chenbowwen currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT kirgizovkirill currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT okamotoyasuhiro currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT seksarnpanya currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT tangyongmin currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT yookeonhee currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT agarwalbharat currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT changodfreycf currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT dalvirashmi currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT horihiroki currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT khanmuhammadsaghir currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT yualice currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup
AT nakagawaraakira currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup